Suppr超能文献

miR-30c-5p 通过靶向 MTA1 抑制胃癌的迁移、侵袭和上皮间质转化。

MiR-30c-5p suppresses migration, invasion and epithelial to mesenchymal transition of gastric cancer via targeting MTA1.

机构信息

Department of Gastroenterology, Zibo Central Hospital, PR China.

Department of Gastroenterology, Zibo Central Hospital, PR China.

出版信息

Biomed Pharmacother. 2017 Sep;93:554-560. doi: 10.1016/j.biopha.2017.06.084. Epub 2017 Jul 4.

Abstract

BACKGROUND

In China, gastric cancer (GC) is an ordinary malignant tumor. Recent literatures have shown that microRNA is critical during tumorigenesis. This study focuses on the influence of miR-30c-5p on the metastasis of GC and further explores its underlying mechanism.

METHODS

Before the study, expression level of miR-30c-5p and targeted protein was detected in 40 GC tissue samples and 5 GC cells by RT-qPCR. Meanwhile, correlation analysis was conducted between miR-30c-5p expression level and clinicopathological features. In addition, wound healing assay and cell invasion assay were utilized to identify whether miR-30c-5p could affect the migrated and invaded ability of GC cells. Western blotting assay and luciferase assay were used to explore the potential mechanism.

RESULTS

In GC tissues, miR-30c-5p expression level was significantly lower and was remarkably related with clinical features such as tumor node metastasis(TNM) stage and lymphatic metastasis. Moreover, the migrated and invaded ability of GC cells was enhanced through knockdown of miR-30c-5p, while overexpression of miR-30c-5p presented with reversed effect. Further study showed that miR-30c-5p inhibited the expression of its target spot, metastasis-associated protein 1(MTA1), and then suppressed the process of epithelial to mesenchymal transition(EMT) which was important in the metastasis of GC.

CONCLUSION

The results indicate that miR-30c-5p, a novel suppressor in tumorigenesis, could inhibit the metastasis and EMT via MTA1, which may offer a possible therapeutic target in GC.

摘要

背景

在中国,胃癌(GC)是一种常见的恶性肿瘤。最近的文献表明,miRNA 在肿瘤发生过程中起着关键作用。本研究关注 miR-30c-5p 对 GC 转移的影响,并进一步探讨其潜在机制。

方法

在研究之前,通过 RT-qPCR 检测了 40 个 GC 组织样本和 5 个 GC 细胞中的 miR-30c-5p 表达水平和靶向蛋白。同时,进行了 miR-30c-5p 表达水平与临床病理特征之间的相关性分析。此外,利用划痕愈合实验和细胞侵袭实验来确定 miR-30c-5p 是否可以影响 GC 细胞的迁移和侵袭能力。通过 Western blot 实验和荧光素酶实验来探索潜在的机制。

结果

在 GC 组织中,miR-30c-5p 的表达水平显著降低,与肿瘤淋巴结转移(TNM)分期和淋巴转移等临床特征显著相关。此外,通过敲低 miR-30c-5p 可增强 GC 细胞的迁移和侵袭能力,而过表达 miR-30c-5p 则呈现出相反的效果。进一步的研究表明,miR-30c-5p 抑制了其靶标转移相关蛋白 1(MTA1)的表达,从而抑制了 EMT 过程,而 EMT 在 GC 的转移中起着重要作用。

结论

研究结果表明,miR-30c-5p 作为一种新的肿瘤发生抑制剂,可通过 MTA1 抑制转移和 EMT,这可能为 GC 提供一种潜在的治疗靶点。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验